Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions
Anna Papa
Katerina Tsergouli
Katerina Tsioka1 - 1Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 2Department of Clinical Microbiology, Institute for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- 3National Veterinary Institute, Uppsala, Sweden
- 4Public Health Agency of Sweden, Stockholm, Sweden
Crimean-Congo hemorrhagic fever virus (CCHFV) is transmitted to humans by bite of infected ticks or by direct contact with blood or tissues of viremic patients or animals. It causes to humans a severe disease with fatality up to 30%. The current knowledge about the vector-host-CCHFV interactions is very limited due to the high-level containment required for CCHFV studies. Among ticks, Hyalomma spp. are considered the most competent virus vectors. CCHFV evades the tick immune response, and following its replication in the lining of the tick's midgut, it is disseminated by the hemolymph in the salivary glands and reproductive organs. The introduction of salivary gland secretions into the host cells is the major route via which CCHFV enters the host. Following an initial amplification at the site of inoculation, the virus is spread to the target organs. Apoptosis is induced via both intrinsic and extrinsic pathways. Genetic factors and immune status of the host may affect the release of cytokines which play a major role in disease progression and outcome. It is expected that the use of new technology of metabolomics, transcriptomics and proteomics will lead to improved understanding of CCHFV-host interactions and identify potential targets for blocking the CCHFV transmission.
Introduction
Crimean-Congo hemorrhagic fever virus (CCHFV, genus Nairovirus, family Bunyaviridae) circulates in nature in an enzootic cycle between ticks and non-human vertebrates and poses a significant public health threat due to its high pathogenicity to humans. Humans are infected by bite of infected Ixodid ticks (mainly Hyalomma spp.), or by contact with blood or tissues of viremic patients or animals. The disease (CCHF) is characterized by abrupt onset of fever, headache, fatigue, and myalgia, as well as gastrointestinal symptoms, such as nausea, vomiting, and diarrhea. Severe cases present hemorrhagic manifestations ranging from petechiae, epistaxis, ecchymosis, and gingival hemorrhage to severe hemorrhages from various systems. The fatality rate is up to 30%. Wild and domestic animals present a short viremia (2–15 days) and they do not develop clinical illness.
CCHFV is a negative sense, single-stranded RNA virus with a tri-segmented genome consisting of the small (S), medium (M), and large (L) segments which encode the nucleocapsid (N) protein, the glycoprotein precursor (which gives rise to the envelope glycoproteins Gn and Gc) and the L protein, respectively. The CCHFV genome is encapsidated by multiple copies of N protein to form a ribonucleocapsid complex which is critical for the virus replication cycle (Carter et al., 2012). The L protein contains a viral RNA-dependent RNA polymerase domain and an ovarian tumor (OTU) domain with deubiquitinating and deISGylating activities, which is thought to suppress immune signaling (Frias-Staheli et al., 2007).
CCHF endemic foci are present in Africa, Asia, and Europe. Its geographic distribution is associated with that of Hyalomma spp. ticks (mainly H. marginatum, H. rufipes, H. anatolicum, and H. asiaticum) which are the main competent vectors of the virus. The term “vector competence” is used to describe the ability of a vector to acquire, maintain and transmit a pathogen. H. marginatum is present in southern Europe and some parts of Asia and Africa. It is characterized by its aggressiveness in seeking human hosts. In CCHF endemic areas, where the climatic and environmental factors are suitable for H. marginatum ticks (and their animal hosts), their population is increased in spring and summer, accounting for >30% of tick species in the area. CCHFV has been detected or isolated from additional tick species, but studies are needed to show whether they are competent virus vectors, or merely coincidental unmaintained tick infection from recent feeding on an infected animal or co-feeding (feeding on an uninfected vertebrate host in close proximity with an infected tick) or the result of a recent blood meal on an infected animal. For an arthropod to be incriminated as an actual vector, several criteria must be met; such as vector competence in laboratory studies, and evidence that the arthropod species feeds in nature on a host that develops an appropriate viremia and that it is active at the time of the year that viral transmission is occurring (Reeves, 1957; Turell, 2007). The virus persists in ticks for the duration of the tick lifespan, while the overwintering of the infected ticks plays a critical role in the maintenance of epidemic foci.
As in most arboviral infections, the main players in CCHF are the vector, the pathogen and the host, resulting in the infection (or not) of the host. The co-evolution of the ticks, hosts and pathogens results in conflict or cooperation between them, benefiting ticks and pathogens and, to a lesser extent, hosts (de la Fuente et al., 2016). CCHFV-infected humans may present asymptomatic, mild, severe, or even fatal disease. The course and the outcome of the disease depend on the individual characteristics of the vector, the virus strain and the host, but also on the vector -pathogen-host interactions. The laboratory studies about these interactions are limited due to the high-level containment required for CCHFV and the lack of an animal model, until recently. In this review we will examine the recent findings on CCHFV and discuss the potential contribution of the new technologies to future research in order to better understand the molecular and cellular basis of these interactions.
Tick-pathogen Interactions
Ticks serve as vectors and reservoirs of CCHFV which can be maintained by transovarial and transstadial (from larva to nymph and adult), and, less efficiently, by venereal transmission (Gonzalez et al., 1992). Ixodid ticks, particularly members of the Hyalomma genus, are considered main competent vectors, while additional tick species may maintain the enzootic foci of CCHFV circulation between ticks and wild and domestic mammals (Hoogstraal, 1979). The virus has to overcome the midgut and the salivary gland barriers in the tick body (Figure 1). Tick vector competence is influenced by the ability of transmitted pathogens to evade tick innate immune response (Hajdusek et al., 2013).
Figure 1. Tick-host-CCHFV interactions. Factors playing a major role are shown in the boxes.
The molecular events at the tick-pathogen interface are not known. Most likely, the first step is the interaction of CCHFV envelope glycoproteins and the epithelial cells of the ticks. The glycoprotein Gc was shown to be a class II viral fusion protein (Garry and Garry, 2004). Like other invertebrates, ticks do not present adaptive immunity, and they rely on innate immune response consisting of phagocytosis, encapsulation, nodulation, and secretion of humoral factors in the hemolymph (McNally and Bloom, 2014). An additional important mechanism of innate antiviral defense of arthropods (including ticks) against arboviruses, RNA interference (RNAi), was investigated on Hazara nairovirus, which is considered as a surrogate CCHFV model. It was shown that small interfering RNAs (siRNAs), targeting Hazara nairovirus N protein mRNA, inhibited virus replication, and the antiviral effect was stronger when siRNAs were combined with ribavirin (Flusin et al., 2011). The exact role of RNAi in tick-CCHFV interactions remains to be elucidated.
Following a blood meal, CCHFV evades the tick humoral and cellular immune responses and replicates in the lining of the tick's midgut; then it is disseminated to the hemolymph and infects various tissues, with highest viral titers being observed in the proliferating tissues (e.g., salivary glands and reproductive tissues) (Dickson and Turell, 1992). The minimum virus titer necessary to infect the ticks varies among tick species (Shepherd et al., 1991). Following intracoelomic inoculation of CCHFV, virus titer is not affected by tick's sex and feeding status (unfed or engorged), but it is positively related with blood feeding (Dickson and Turell, 1992). CCHFV replication in tissues of an infected tick may be stimulated by tick attachment and feeding on a susceptible host, probably by reducing the stress on a tick induced by viral replication while the tick is waiting to find a vertebrate host, but increase the potential for viral transmission once a host had been acquired (Turell, 2007).
Using a transmission model for CCHFV and next generation sequencing it was shown that many mutations in CCHFV were recovered from ticks after only a single transstadial transmission, whereas no mutations were detected in CCHFV recovered from the mammalian host, with greater viral intra-host diversity in the tick rather than the vertebrate host (Xia et al., 2016).
CCHFV is generally not the sole microbe in ticks; endosymbionts and several pathogens may be present at the same time (Papa et al., 2017). Metagenomic studies showed that the microbiome has an effect on tick fitness and pathogen infection and transmission. As an example, Francisella-like endosymbionts have been detected in Hyalomma spp. ticks (Ivanov et al., 2011; Szigeti et al., 2014). Although the presence of additional pathogens or endosymbionts may affect the physiology and immune response of the ticks, there are no related studies.
Viral infections in ticks are not entirely silent and may affect the tick survival, behavior and gene expression (McNally and Bloom, 2014). Next generation sequencing of infected and uninfected ticks microbiome may give more insights into the interactions between pathogens and ticks.
Tick-host Interactions
The general issues concerning tick-host interactions likely apply to CCHFV. The first contact between the tick and the host occurs during the tick bite and the prolonged complex process of the tick feeding on the host. The introduction of salivary gland secretions into the feeding lesion is the major, if not exclusive, route via which pathogens and toxins access the vertebrate host and mediate the host reactions (Kaufman, 1989). Despite the host's hemostatic, inflammatory and immune responses, the tick manages to remain attached for blood-feeding via the pharmacy located in its salivary glands and secreted in saliva. Anticoagulants, cytolytic substances, vasoactive mediatiors (such as prostaglandins) and cement, which anchors the mouthparts to the skin, are among the secreted agents. Saliva activated transmission, subsequently renamed saliva-assisted transmission (SAT), affects the host in ways that are exploited by many pathogens to facilitate infection (Nuttall, 1999); SAT is thought to play an additional critical role facilitating the infection of uninfected ticks feeding at the same time on the same host in the absence of an overt host viremia (co-feeding or mechanical transmission) (Gordon et al., 1993). There are no reports on the role of SAT on CCHFV. Because the salivary glands are the most important route for pathogen transmission by arthropod vectors, it is expected that the volume of saliva secreted into the host would be a major factor determining the efficacy of transmission (Kaufman, 2010). Time of attachment may also affect the level of tick-host interaction. Abiotic (environmental and climatic) factors are involved indirectly in the tick-host interactions by playing a role in the abundance and aggressiveness of ticks, thus affecting the chance of a host to be bitten by ticks (Figure 1).
Host-pathogen Interactions
CCHFV must overcome the epithelium and preferentially escape at the basolateral membrane of epithelial cells to establish infection (Connolly-Andersen et al., 2007). CCHFV replicates to high titers at the site of inoculation, in epithelial cells, dendritic cells, and tissue resident macrophages. The productive infection of these cells facilitates spread of the virus and results in early infection of local lymph nodes and peripheral blood-borne monocytes supporting systematic spread of the virus (Burt et al., 1997; Connolly-Andersen et al., 2009; Akinci et al., 2013).
To date the receptor of CCHFV in target cells is not known. The viral glycoproteins Gn and/or Gc are involved in the initial attachment of CCHFV to the cell plasma membrane. It was suggested that Gc is responsible for binding to the cellular receptors, and mediates fusion later, during the early step of replication cycle. An interaction between CCHFV glycoproteins and cell surface nucleolin, a protein found predominantly within nucleoli, has been suggested as putative entry factor; however, more investigations are needed to support the involvement of nucleolin in CCHFV internalization (Xiao et al., 2011). CCHFV enters the cells using clathrin- and the clathrin pit adaptor protein-2 complex, but not caveolin-1 (Simon et al., 2009a; Garrison et al., 2013). Internalization is cholesterol- and pH-dependent (Simon et al., 2009b). Then, CCHFV particles are transported to early endosomes and to multivesicular bodies where the fusion of the virus envelope with cellular membranes takes place. These processes use components of the endosomal sorting complex required for transport regulators (Shtanko et al., 2014).
Cytoskeleton components, including microtubulin and actin filaments, are essential for CCHFV internalization, replication and progeny virus production (Andersson et al., 2004; Simon et al., 2009a). The predicted actin-interacting domain is localized within the central stalk region of the CCHFV N protein adjacent to the coiled-coil motif. The key residue responsible for N protein-actin interaction, D219, and is also crucial for self-association of the N protein (Levingston Macleod et al., 2015). Furthermore, it has been recently shown that the CCHFV N protein interacts with cellular chaperones of the heat shock protein 70 family (including actin), which, in association with DnaJ cofactor adapter proteins, play roles that relate to correct folding and transport of newly synthesized and misfolded proteins and to the assembly of multicomponent complexes (Surtees et al., 2016). One other protein which has been recently demonstrated to be involved in CCHFV replication is aquaporin 6, a water channel that facilitates fluxes of water and small solutes across membranes (Molinas et al., 2016).
The infection of endothelial cells and peripheral blood-borne monocytes results in extravasation into parenchymal tissue enabling the virus to interact with basolateral cells receptors in target organs (Connolly-Andersen et al., 2007). Secondary replication in these organs facilitates the systemic spread of the virus in humans (Akinci et al., 2013). This theory is supported by studies in animal models, which showed that on the first day of infection, the viral replication occurs in the blood, on the second day in spleen and liver, and then spreads systemically to the lungs, kidneys, and brain (Bente et al., 2010).
The virus enters the blood stream overcoming the vascular endothelial surface barrier and the endothelial junctions (Becker et al., 2010). Endothelial cells are targeted either directly by the virus, or indirectly, by virus-induced host-derived soluble mediators that cause endothelial activation (Connolly-Andersen et al., 2011). This has been previously demonstrated for other viral hemorrhagic fevers (Schnittler and Feldmann, 2003). To date, it is not known how CCHFV causes microvascular instability. It is more likely that it is mediated indirectly by increased levels of proinflammatory cytokines, or by a combination of virus infection and the cytokine storm (Connolly-Andersen et al., 2007; Papa et al., 2016).
The endothelial damage is responsible for hemostatic failure by stimulating aggregation and degranulation of the platelets, and activation of the intrinsic coagulation cascade (Weber and Mirazimi, 2008; Bodur et al., 2010). During CCHFV infection, apart from the activated macrophages, an increase in the numbers of natural killer cells and CD3+ CD8+ T cells is observed (Yilmaz et al., 2008; Akinci et al., 2009). But as the disease progresses, the uncontrolled apoptosis of lymphocytes contributes to a depletion in lymphocyte counts, which is presented as lymphopenia (Bente et al., 2010). It has been demonstrated that CCHFV infection can induce apoptosis indirectly, through the release of cytokines from infected cells (Karlberg et al., 2015). This finding fits nicely with the hypothesis described above. Recently it has been shown that CCHFV codes for a non-structural protein, NSs, which may induce apoptosis via both intrinsic and extrinsic pathways (Barnwal et al., 2016).
Soon after the presentation of CCHFV antigen to host cells, innate and adaptive immune responses are activated (Figure 1). DC-SIGN (a calcium-dependent [C-type] lectin cell-surface molecule), which is expressed in the antigen-presenting dendritic cells, was suggested as probable entry factor for CCHFV (Suda et al., 2016). In vitro studies showed that RIG-I acts as a pattern recognition receptor for CCHFV and mediates a type I interferon (IFN) antiviral response via the cellular adaptor MAVS (Spengler et al., 2015). As in other viral hemorrhagic fevers, replicating CCHFV delays substantially the IFN response, possibly by interfering with the activation pathway of IRF-3, allowing the rapid viral spread in the host (Andersson et al., 2008). Downregulation of IFN-I signaling pathways relies on the cleavage of ubiquitin and ISG15 from various host proteins (Frias-Staheli et al., 2007). It is of interest that the related CCHFV OTU proteases show clear preferences for ISG15s from certain mammalian species (Deaton et al., 2016).
Several cytokines and chemokines are released during the course of CCHF, especially in severe cases (Ergonul et al., 2006; Papa et al., 2006, 2015, 2016; Saksida et al., 2010). Preliminary analysis showed that the expression of microRNAs related to regulation of cytokine expression is altered in CCHF patients (Demir et al., 2017). Genetic factors and immune status of the host, as well as genetic differences in CCHFV strains, may play a significant role in the virus-host interface, however, there are no studies available.
Tools for Research on Tick-host-CCHFV Interactions
Tick cell lines are now available to enable the CCHFV studies in vitro, offering an alternative approach to understand the way that tick cells respond to virus infection (Bell-Sakyi et al., 2012). The recent development of CCHF virus-like particle (VLP) systems can be used to study cell entry and viral transcription and replication (Devignot et al., 2015; Zivcec et al., 2015). The fact that VLPs are non-infectious will greatly facilitate the tick-pathogen interaction studies under non-BSL-4 conditions. The widespread adaptation of RNA interference (RNAi) will aid in studying tick gene functions (de la Fuente et al., 2005). Interferon response knockout mice have been recently described as animal models for CCHF (Bente et al., 2010; Bereczky et al., 2010; Zivcec et al., 2013). An in vivo transmission model for CCHFV in a BSL4 biocontainment was established recently using interferon knockout mice, which is an additional tool to study the transmission and interaction of CCHFV with its tick vector (Gargili et al., 2013). Advances in the study of molecular events at the tick-host-pathogen interface are expected by the increasing number of available genomic resources, including metabolomics, transcriptomics and proteomics. Mathematical and relational models are being constructed for the challenging integration of multi-source datasets from biological systems and cellular networks that would improve our understanding of CCHF pathogenesis (Vidal et al., 2011; Gomez-Cabrero et al., 2014).
Future Perspectives
Over the last decades considerable progress has been made in the identification of the cellular components involved in tick-host-pathogen interactions. However, there is limited knowledge so far in the case of CCHFV due to the high-level containment required for studies with the virus. The identification of the molecular drivers that promote CCHFV survival in the tick, persistence and pathogen transmission provides the opportunity to disrupt these processes and lead to a reduction in tick burden and prevalence of tick-borne diseases (De la Fuente et al., 2017), while the identification of the molecular signaling pathways taking place during the CCHFV-host interactions provides the opportunity to design novel control and vaccine strategies for CCHF. Potential targets could be the cell fusion step during virus entry to the host cells (Garry and Garry, 2004), the pattern recognition receptors for CCHFV (Spengler et al., 2015), the chaperones of the HSP70 family (Surtees et al., 2016), the OTU domain (Frias-Staheli et al., 2007), and the immunogenic factors (Papa et al., 2016). Scientists now have tremendous opportunities to utilize new technologies and in vitro models to increase our understanding of CCHFV pathogenesis for the good of Public Health.
Author Contributions
AP wrote the first draft of the article. KTse, KTsi, and AM contributed to the writing of the article. All authors worked for the final version of the article.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The study is part of EU projects ANTIGONE (grant agreement No. 278976) and COMPARE (grant agreement No. 643476) and Arbonet within the ANHIWA platform.
References
Akinci, E., Bodur, H., and Leblebicioglu, H. (2013). Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 13, 429–437. doi: 10.1089/vbz.2012.1061
Akinci, E., Yilmaz, M., Bodur, H., Onguru, P., Bayazit, F. N., Erbay, A., et al. (2009). Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 13, 560–563. doi: 10.1016/j.ijid.2008.08.027
Andersson, I., Karlberg, H., Mousavi-Jazi, M., Martinez-Sobrido, L., Weber, F., and Mirazimi, A. (2008). Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J. Med. Virol. 80, 1397–1404. doi: 10.1002/jmv.21222
Andersson, I., Simon, M., Lundkvist, A., Nilsson, M., Holmstrom, A., Elgh, F., et al. (2004). Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells. J. Med. Virol. 72, 83–93. doi: 10.1002/jmv.10560
Barnwal, B., Karlberg, H., Mirazimi, A., and Tan, Y. J. (2016). The non-structural protein of Crimean-Congo hemorrhagic fever virus disrupts the mitochondrial membrane potential and induces Apoptosis. J. Biol. Chem. 291, 582–592. doi: 10.1074/jbc.M115.667436
Becker, B. F., Chappell, D., and Jacob, M. (2010). Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res. Cardiol. 105, 687–701. doi: 10.1007/s00395-010-0118-z
Bell-Sakyi, L., Kohl, A., Bente, D. A., and Fazakerley, J. K. (2012). Tick cell lines for study of Crimean-Congo hemorrhagic fever virus and other arboviruses. Vector Borne Zoonotic Dis. 12, 769–781. doi: 10.1089/vbz.2011.0766
Bente, D. A., Alimonti, J. B., Shieh, W. J., Camus, G., Stroher, U., Zaki, S., et al. (2010). Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84, 11089–11100. doi: 10.1128/JVI.01383-10
Bereczky, S., Lindegren, G., Karlberg, H., Akerstrom, S., Klingstrom, J., and Mirazimi, A. (2010). Crimean Congo haemorrhagic fever virus infection is lethal for adult 1 type I interferon receptor knock-out mice. J. Gen. Virol. 91, 1473–1477. doi: 10.1099/vir.0.019034-0
Bodur, H., Akinci, E., Onguru, P., Uyar, Y., Basturk, B., Gozel, M. G., et al. (2010). Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 14, e704–e707. doi: 10.1016/j.ijid.2010.02.2240
Burt, F. J., Swanepoel, R., Shieh, W. J., Smith, J. F., Leman, P. A., Greer, P. W., et al. (1997). Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121, 839–846.
Carter, S. D., Surtees, R., Walter, C. T., Ariza, A., Bergeron, E., Nichol, S. T., et al. (2012). Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Virol. 86, 10914–10923. doi: 10.1128/JVI.01555-12
Connolly-Andersen, A. M., Douagi, I., Kraus, A. A., and Mirazimi, A. (2009). Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 390, 157–162. doi: 10.1016/j.virol.2009.06.010
Connolly-Andersen, A. M., Magnusson, K. E., and Mirazimi, A. (2007). Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J. Virol. 81, 2158–2164. doi: 10.1128/JVI.02070-06
Connolly-Andersen, A. M., Moll, G., Andersson, C., Akerstrom, S., Karlberg, H., Douagi, I., et al. (2011). Crimean-Congo hemorrhagic fever virus activates endothelial cells. J. Virol. 85, 7766–7774. doi: 10.1128/JVI.02469-10
Deaton, M. K., Dzimianski, J. V., Daczkowski, C. M., Whitney, G. K., Mank, N. J., Parham, M. M., et al. (2016). Biochemical and structural insights into the preference of nairoviral deISGylases for interferon-stimulated gene product 15 originating from certain species. J. Virol. 90, 8314–8327. doi: 10.1128/JVI.00975-16
de la Fuente, J., Almazan, C., Blouin, E. F., Naranjo, V., and Kocan, K. M. (2005). RNA interference screening in ticks for identification of protective antigens. Parasitol. Res. 96, 137–141. doi: 10.1007/s00436-005-1351-5
De la Fuente, J., Antunes, S., Bonnet, S., Cabezas-Cruz, A., Domingos, A. G., Estrada-peña, A., et al. (2017). Tick-pathogen interactions and vector competence: identification of molecular drivers for tick-borne diseases Front. Cell. Infect. Microbiol. 7:114. doi: 10.3389/fcimb.2017.00114
de la Fuente, J., Villar, M., Cabezas-Cruz, A., Estrada-Pena, A., Ayllon, N., and Alberdi, P. (2016). Tick-host-pathogen interactions: conflict and cooperation. PLoS Pathog. 12:e1005488. doi: 10.1371/journal.ppat.1005488
Demir, Z. C., Bastug, A., Bodur, H., Ergunay, K., and Ozkul, A. (2017). MicroRNA expression profiles in patients with acute Crimean Congo hemorrhagic fever reveal possible adjustments to cellular pathways. J. Med. Virol. 89, 417–422. doi: 10.1002/jmv.24667
Devignot, S., Bergeron, E., Nichol, S., Mirazimi, A., and Weber, F. (2015). A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus. J. Virol. 89, 5957–5967. doi: 10.1128/JVI.03691-14
Dickson, D. L., and Turell, M. J. (1992). Replication and tissue tropisms of Crimean-Congo hemorrhagic fever virus in experimentally infected adult Hyalomma truncatum (Acari: Ixodidae). J. Med. Entomol. 29, 767–773. doi: 10.1093/jmedent/29.5.767
Ergonul, O., Tuncbilek, S., Baykam, N., Celikbas, A., and Dokuzoguz, B. (2006). Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193, 941–944. doi: 10.1086/500836
Flusin, O., Vigne, S., Peyrefitte, C. N., Bouloy, M., Crance, J. M., and Iseni, F. (2011). Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. Virol. J. 8:249. doi: 10.1186/1743-422X-8-249
Frias-Staheli, N., Giannakopoulos, N. V., Kikkert, M., Taylor, S. L., Bridgen, A., Paragas, J., et al. (2007). Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe. 2, 404–416. doi: 10.1016/j.chom.2007.09.014
Gargili, A., Thangamani, S., and Bente, D. (2013). Influence of laboratory animal hosts on the life cycle of Hyalomma marginatum and implications for an in vivo transmission model for Crimean-Congo hemorrhagic fever virus. Front. Cell. Infect. Microbiol. 3:39. doi: 10.3389/fcimb.2013.00039
Garrison, A. R., Radoshitzky, S. R., Kota, K. P., Pegoraro, G., Ruthel, G., Kuhn, J. H., et al. (2013). Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology 444, 45–54. doi: 10.1016/j.virol.2013.05.030
Garry, C. E., and Garry, R. F. (2004). Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor. Biol. Med. Model. 1:10. doi: 10.1186/1742-4682-1-10
Gomez-Cabrero, D., Abugessaisa, I., Maier, D., Teschendorff, A., Merkenschlager, M., Gisel, A., et al. (2014). Data integration in the era of omics: current and future challenges. BMC Syst. Biol. 8(Suppl. 2):I1. doi: 10.1186/1752-0509-8-S2-I1
Gonzalez, J. P., Camicas, J. L., Cornet, J. P., Faye, O., and Wilson, M. L. (1992). Sexual and transovarian transmission of Crimean-Congo haemorrhagic fever virus in Hyalomma truncatum ticks. Res. Virol. 143, 23–28. doi: 10.1016/S0923-2516(06)80073-7
Gordon, S. W., Linthicum, K. J., and Moulton, J. R. (1993). Transmission of Crimean-Congo hemorrhagic fever virus in two species of Hyalomma ticks from infected adults to cofeeding immature forms. Am. J. Trop. Med. Hyg. 48, 576–580. doi: 10.4269/ajtmh.1993.48.576
Hajdusek, O., Sima, R., Ayllon, N., Jalovecka, M., Perner, J., de la Fuente, J., et al. (2013). Interaction of the tick immune system with transmitted pathogens. Front. Cell. Infect. Microbiol. 3:26. doi: 10.3389/fcimb.2013.00026
Hoogstraal, H. (1979). The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 15, 307–417. doi: 10.1093/jmedent/15.4.307
Ivanov, I. N., Mitkova, N., Reye, A. L., Hubschen, J. M., Vatcheva-Dobrevska, R. S., Dobreva, E. G., et al. (2011). Detection of new Francisella-like tick endosymbionts in Hyalomma spp. and Rhipicephalus spp. (Acari: Ixodidae) from Bulgaria. Appl. Environ. Microbiol. 77, 5562–5565. doi: 10.1128/AEM.02934-10
Karlberg, H., Tan, Y. J., and Mirazimi, A. (2015). Crimean-Congo haemorrhagic fever replication interplays with regulation mechanisms of apoptosis. J. Gen. Virol. 96, 538–546. doi: 10.1099/jgv.0.000011
Kaufman, W. R. (1989). Tick-host interaction: a synthesis of current concepts. Parasitol. Today 5, 47–56. doi: 10.1016/0169-4758(89)90191-9
Kaufman, W. R. (2010). Ticks: physiological aspects with implications for pathogen transmission. Ticks Tick Borne Dis. 1, 11–22. doi: 10.1016/j.ttbdis.2009.12.001
Levingston Macleod, J. M., Marmor, H., Garcia-Sastre, A., and Frias-Staheli, N. (2015). Mapping of the interaction domains of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Gen. Virol. 96, 524–537. doi: 10.1099/vir.0.071332-0
McNally, K. L., and Bloom, M. E. (2014). “The tick-virus interface,” in Viral Infections and Global Change, ed S. K. Singh (Hoboken, NJ: Wiley), 603–616.
Molinas, A., Mirazimi, A., Holm, A., Loitto, V. M., Magnusson, K. E., and Vikstrom, E. (2016). Protective role of host aquaporin 6 against Hazara virus, a model for Crimean-Congo hemorrhagic fever virus infection. FEMS Microbiol. Lett. 363:fnw058. doi: 10.1093/femsle/fnw058
Nuttall, P. A. (1999). Pathogen-tick-host interactions: Borrelia burgdorferi and TBE virus. Zentralbl. Bakteriol. 289, 492–505. doi: 10.1016/S0934-8840(99)80002-4
Papa, A., Bino, S., Velo, E., Harxhi, A., Kota, M., and Antoniadis, A. (2006). Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36, 272–276. doi: 10.1016/j.jcv.2006.04.007
Papa, A., Tsergouli, K., Caglayik, D. Y., Bino, S., Como, N., Uyar, Y., et al. (2016). Cytokines as biomarkers of Crimean-Congo hemorrhagic fever. J. Med. Virol. 88, 21–27. doi: 10.1002/jmv.24312
Papa, A., Tsioka, K., Kontana, A., Papadopoulos, C., and Giadinis, N. (2017). Bacterial pathogens and endosymbionts in ticks. Ticks Tick Borne Dis. 8, 31–35. doi: 10.1016/j.ttbdis.2016.09.011
Papa, A., Yagci Caglayik, D., Christova, I., Tsergouli, K., Korukluoglu, G., and Uyar, Y. (2015). Crimean-Congo hemorrhagic fever: CXCL10 correlates with the viral load. J. Med. Virol. 87, 899–903. doi: 10.1002/jmv.24141
Reeves, W. C. (1957). “Arthropods as vectors and reservoirs of animal pathogenic viruses,” in Handbuch der Virusforschung, eds C. Hallauer and K. F. Meyer (Vienna: Springer-Verlag), 177–202.
Saksida, A., Duh, D., Wraber, B., Dedushaj, I., Ahmeti, S., and Avsic-Zupanc, T. (2010). Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin. Vaccine Immunol. 17, 1086–1093. doi: 10.1128/CVI.00530-09
Schnittler, H. J., and Feldmann, H. (2003). Viral hemorrhagic fever–a vascular disease? Thromb. Haemost. 89, 967–972.
Shepherd, A. J., Swanepoel, R., Shepherd, S. P., Leman, P. A., and Mathee, O. (1991). Viraemic transmission of Crimean-Congo haemorrhagic fever virus to ticks. Epidemiol. Infect. 106, 373–382. doi: 10.1017/S0950268800048524
Shtanko, O., Nikitina, R. A., Altuntas, C. Z., Chepurnov, A. A., and Davey, R. A. (2014). Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog. 10:e1004390. doi: 10.1371/journal.ppat.1004390
Simon, M., Johansson, C., Lundkvist, A., and Mirazimi, A. (2009a). Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology 385, 313–322. doi: 10.1016/j.virol.2008.11.020
Simon, M., Johansson, C., and Mirazimi, A. (2009b). Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 90, 210–215. doi: 10.1099/vir.0.006387-0
Spengler, J. R., Patel, J. R., Chakrabarti, A. K., Zivcec, M., Garcia-Sastre, A., Spiropoulou, C. F., et al. (2015). RIG-I Mediates an antiviral response to crimean-congo hemorrhagic fever virus. J. Virol. 89, 10219–10229. doi: 10.1128/JVI.01643-15
Suda, Y., Fukushi, S., Tani, H., Murakami, S., Saijo, M., Horimoto, T., et al. (2016). Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system. Arch. Virol. 161, 1447–1454. doi: 10.1007/s00705-016-2803-1
Surtees, R., Dowall, S. D., Shaw, A., Armstrong, S., Hewson, R., Carroll, M. W., et al. (2016). Heat shock protein 70 family members interact with Crimean-Congo hemorrhagic fever virus and Hazara virus nucleocapsid proteins and perform a functional role in the Nairovirus replication cycle. J. Virol. 90, 9305–9316. doi: 10.1128/JVI.00661-16
Szigeti, A., Kreizinger, Z., Hornok, S., Abichu, G., and Gyuranecz, M. (2014). Detection of Francisella-like endosymbiont in Hyalomma rufipes from Ethiopia. Ticks Tick Borne Dis. 5, 818–820. doi: 10.1016/j.ttbdis.2014.06.002
Turell, M. J. (2007). “Role of ticks in the transmission of Crimean-Congo hemorrhagic fever virus,” in Crimean-Congo Hemorrhagic Fever, eds O. O. Ergonul and C. A. Whitehouse (Dordrecht: Springer), 143–154.
Vidal, M., Cusick, M. E., and Barabasi, A. L. (2011). Interactome networks and human disease. Cell 144, 986–998. doi: 10.1016/j.cell.2011.02.016
Weber, F., and Mirazimi, A. (2008). Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 19, 395–404. doi: 10.1016/j.cytogfr.2008.11.001
Xia, H., Beck, A. S., Gargili, A., Forrester, N., Barrett, A. D., and Bente, D. A. (2016). Transstadial transmission and long-term association of Crimean-Congo hemorrhagic fever virus in ticks shapes genome plasticity. Sci. Rep. 6:35819. doi: 10.1038/srep35819
Xiao, X., Feng, Y., Zhu, Z., and Dimitrov, D. S. (2011). Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 411, 253–258. doi: 10.1016/j.bbrc.2011.06.109
Yilmaz, M., Aydin, K., Akdogan, E., Sucu, N., Sonmez, M., Omay, S. B., et al. (2008). Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 42, 415–417. doi: 10.1016/j.jcv.2008.03.003
Zivcec, M., Metcalfe, M. G., Albarino, C. G., Guerrero, L. W., Pegan, S. D., Spiropoulou, C. F., et al. (2015). Assessment of inhibitors of pathogenic Crimean-Congo Hemorrhagic fever virus strains using virus-like particles. PLoS Negl. Trop. Dis. 9:e0004259. doi: 10.1371/journal.pntd.0004259
Zivcec, M., Safronetz, D., Scott, D., Robertson, S., Ebihara, H., and Feldmann, H. (2013). Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J. Infect. Dis. 207, 1909–1921. doi: 10.1093/infdis/jit061
Keywords: Crimean-Congo hemorrhagic fever virus, tick, humans, interactions, immune response
Citation: Papa A, Tsergouli K, Tsioka K and Mirazimi A (2017) Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions. Front. Cell. Infect. Microbiol. 7:213. doi: 10.3389/fcimb.2017.00213
Received: 27 March 2017; Accepted: 11 May 2017;
Published: 26 May 2017.
Edited by:
Sarah Irène Bonnet, Institut National de la Recherche Agronomique (INRA), FranceReviewed by:
Kui Li, University of Tennessee Health Science Center, United StatesDan Drecktrah, University of Montana, United States
Copyright © 2017 Papa, Tsergouli, Tsioka and Mirazimi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Anna Papa, annap@med.auth.gr